[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]. (Record no. 17081556)

MARC details
000 -LEADER
fixed length control field 01469 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515071405.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200706s 0 0 ger d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1439-4413
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-2007-982025
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Joussen, A M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070628
245 00 - TITLE STATEMENT
Title [Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Deutsche medizinische Wochenschrift (1946)
Date of publication, distribution, etc. Jun 2007
300 ## - PHYSICAL DESCRIPTION
Extent 1268-72 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiogenesis Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aptamers, Nucleotide
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetic Angiopathies
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetic Retinopathy
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infant, Newborn
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macular Degeneration
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neovascularization, Pathologic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ranibizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retinal Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retinopathy of Prematurity
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Diseases
General subdivision drug therapy
773 0# - HOST ITEM ENTRY
Title Deutsche medizinische Wochenschrift (1946)
Related parts vol. 132
-- no. 23
-- p. 1268-72
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-2007-982025">https://doi.org/10.1055/s-2007-982025</a>
Public note Available from publisher's website

No items available.